• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Crk样衔接蛋白在甲状腺微小乳头状癌中的表达的临床意义

The clinical implications of Crk-like adaptor protein expression in papillary thyroid microcarcinoma.

作者信息

Yang Xiangshan, Lv Wenyuan, Shi Ranran, Cheng Shaomei, Zhang Jing, Xu Zhongfa

机构信息

Department of Pathology, Affiliated Hospital of Shandong Academy of Medical Sciences, Jinan, Shandong, China.

出版信息

Tumour Biol. 2014 Dec;35(12):12435-40. doi: 10.1007/s13277-014-2561-1. Epub 2014 Sep 4.

DOI:10.1007/s13277-014-2561-1
PMID:25185652
Abstract

Papillary thyroid microcarcinoma (PMC) is the most common subtype of thyroid carcinomas with satisfactory prognosis. Crk-like (CrkL) adaptor protein was identified in the development of many carcinomas. However, the clinical implications of CrkL protein in PMC were still unknown. Here, we conducted immunohistochemistry to test and analyze CrkL expression in papillary thyroid carcinoma (PTC) (50 cases), PMC (50 cases), and nodular goiter (50 cases), and then western blot further identified the expression of CrkL proteins. In our present study, the positive rate and the mean optical density (MOD) value of CrkL expression in PTC and PMC tissues were statistically significantly different, compared with nodular goiter (p = 0.021, 0.037) and normal thyroid tissues (p = 0.003, 0.009), respectively. In addition, CrkL expression was not associated with age, gender, and tumor number. Conversely, significant differences between CrkL expression and metastasis (p < 0.01) and violation of capsule (p < 0.01) were observed. Notably, western blot indeed identified that the metastasis group of either PTC or PMC tissues had about twofold increased expression of CrkL compared with their non-metastasis groups (p < 0.05). In conclusion, CrkL is highly expressed in papillary thyroid carcinoma and papillary thyroid microcarcinoma and closely correlated to metastasis. Therefore, it is essential to carry out neck lymph node clearance in patients with papillary thyroid microcarcinoma.

摘要

甲状腺乳头状微小癌(PMC)是甲状腺癌最常见的亚型,预后良好。在许多癌症的发生发展过程中发现了类Crk(CrkL)衔接蛋白。然而,CrkL蛋白在PMC中的临床意义仍不清楚。在此,我们进行免疫组化检测并分析CrkL在甲状腺乳头状癌(PTC,50例)、PMC(50例)和结节性甲状腺肿(50例)中的表达,然后通过蛋白质印迹法进一步鉴定CrkL蛋白的表达。在本研究中,与结节性甲状腺肿(p = 0.021,0.037)和正常甲状腺组织(p = 0.003,0.009)相比,PTC和PMC组织中CrkL表达的阳性率和平均光密度(MOD)值在统计学上有显著差异。此外,CrkL表达与年龄、性别和肿瘤数量无关。相反,观察到CrkL表达与转移(p < 0.01)和包膜侵犯(p < 0.01)之间存在显著差异。值得注意的是,蛋白质印迹法确实鉴定出,与非转移组相比,PTC或PMC组织的转移组中CrkL的表达增加了约两倍(p < 0.05)。总之,CrkL在甲状腺乳头状癌和甲状腺乳头状微小癌中高表达,且与转移密切相关。因此,对甲状腺乳头状微小癌患者进行颈部淋巴结清扫至关重要。

相似文献

1
The clinical implications of Crk-like adaptor protein expression in papillary thyroid microcarcinoma.Crk样衔接蛋白在甲状腺微小乳头状癌中的表达的临床意义
Tumour Biol. 2014 Dec;35(12):12435-40. doi: 10.1007/s13277-014-2561-1. Epub 2014 Sep 4.
2
[Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].[微小RNA-221和白细胞介素-17在甲状腺乳头状癌中的表达及其与临床病理特征的相关性]
Zhonghua Bing Li Xue Za Zhi. 2017 Mar 8;46(3):160-165. doi: 10.3760/cma.j.issn.0529-5807.2017.03.004.
3
Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma.表皮生长因子受体过表达是甲状腺乳头状癌不良病理特征的标志物。
J Surg Res. 2013 Nov;185(1):217-24. doi: 10.1016/j.jss.2013.05.003. Epub 2013 May 23.
4
Significance of p53-binding protein 1 (53BP1) expression in thyroid papillary microcarcinoma: association with BRAFV600E mutation status.p53 结合蛋白 1(53BP1)在甲状腺微小乳头状癌中的表达意义:与 BRAFV600E 突变状态的关联。
Histopathology. 2013 Nov;63(5):726-34. doi: 10.1111/his.12233. Epub 2013 Sep 5.
5
[Aberrant methylation of hMLH1 gene promoter in papillary thyroid cancer and its clinical significance].甲状腺乳头状癌中hMLH1基因启动子的异常甲基化及其临床意义
Zhonghua Zhong Liu Za Zhi. 2013 Nov;35(11):833-6.
6
Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing.甲状腺乳头状癌组织中 miR-486-5p 的下调:基于微阵列和 miRNA 测序的研究。
Mol Med Rep. 2018 Sep;18(3):2631-2642. doi: 10.3892/mmr.2018.9247. Epub 2018 Jul 3.
7
[Usefulness of CK19, HBME-1 and galectin-3 expressions in differential diagnosis of thyroid papillary microcarcinoma from benign lesions].[CK19、HBME-1和半乳糖凝集素-3表达在甲状腺微小乳头状癌与良性病变鉴别诊断中的应用价值]
Zhonghua Zhong Liu Za Zhi. 2011 Aug;33(8):599-604.
8
Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter.γH2AX在甲状腺乳头状癌和结节性甲状腺肿中的差异表达。
Clin Lab. 2014;60(12):2031-7. doi: 10.7754/clin.lab.2014.140603.
9
[Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].[甲状腺乳头状癌患者血清E-钙黏蛋白的表达及意义]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Jan 20;31(2):123-126. doi: 10.13201/j.issn.1001-1781.2017.02.010.
10
Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.利用超声引导下细针穿刺活检样本的蛋白质组学分析破译甲状腺乳头状微癌淋巴结转移的新型生物标志物。
J Proteomics. 2019 Jul 30;204:103414. doi: 10.1016/j.jprot.2019.103414. Epub 2019 Jun 10.

引用本文的文献

1
Crk and CrkL as Therapeutic Targets for Cancer Treatment.Crk 和 CrkL 作为癌症治疗的治疗靶点。
Cells. 2021 Mar 27;10(4):739. doi: 10.3390/cells10040739.
2
Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity.定量评估体外脑胶质瘤表型可将细胞迁移作为 Crk 和 CrkL 活性的可靠读出。
J Biol Chem. 2021 Jan-Jun;296:100390. doi: 10.1016/j.jbc.2021.100390. Epub 2021 Feb 6.
3
Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing.

本文引用的文献

1
Involvement of level IIb lymph node metastasis and dissection in thyroid cancer.甲状腺癌中Ⅱb级淋巴结转移及清扫情况
Gland Surg. 2013 Nov;2(4):180-5. doi: 10.3978/j.issn.2227-684X.2013.10.04.
2
ACR Appropriateness Criteria® thyroid carcinoma.ACR 适宜性标准®甲状腺癌。
Oral Oncol. 2014 Jun;50(6):577-86. doi: 10.1016/j.oraloncology.2013.12.004.
3
BRAF genetic heterogeneity in papillary thyroid carcinoma and its metastasis.甲状腺乳头癌及其转移中的 BRAF 基因异质性。
甲状腺乳头状癌组织中 miR-486-5p 的下调:基于微阵列和 miRNA 测序的研究。
Mol Med Rep. 2018 Sep;18(3):2631-2642. doi: 10.3892/mmr.2018.9247. Epub 2018 Jul 3.
Hum Pathol. 2014 May;45(5):935-41. doi: 10.1016/j.humpath.2013.12.005. Epub 2014 Jan 8.
4
The association of Crk-like adapter protein with poor prognosis in glioma patients.Crk样衔接蛋白与胶质瘤患者预后不良的相关性。
Tumour Biol. 2014 Jun;35(6):5695-700. doi: 10.1007/s13277-014-1754-y. Epub 2014 Feb 22.
5
Sunitinib therapy in metastatic papillary thyroid cancer.舒尼替尼治疗转移性甲状腺乳头状癌。
Tumori. 2013 Nov-Dec;99(6):285e-7e. doi: 10.1700/1390.15470.
6
Autophagy, a novel target for chemotherapeutic intervention of thyroid cancer.自噬:甲状腺癌化疗干预的新靶点
Cancer Chemother Pharmacol. 2014 Mar;73(3):439-49. doi: 10.1007/s00280-013-2363-y. Epub 2013 Dec 4.
7
Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.甲状腺微小乳头状癌的癌症复发:对231例患者进行12年随访的多因素分析
Minerva Endocrinol. 2013 Sep;38(3):269-79.
8
Crystal structure of Src-like adaptor protein 2 reveals close association of SH3 and SH2 domains through β-sheet formation.Src 样衔接蛋白 2 的晶体结构揭示了 SH3 结构域和 SH2 结构域通过β-折叠形成紧密关联。
Cell Signal. 2013 Dec;25(12):2702-8. doi: 10.1016/j.cellsig.2013.08.040. Epub 2013 Sep 7.
9
Overexpression of CRKL correlates with malignant cell proliferation in breast cancer.CRKL的过表达与乳腺癌中的恶性细胞增殖相关。
Tumour Biol. 2013 Oct;34(5):2891-7. doi: 10.1007/s13277-013-0851-7. Epub 2013 May 19.
10
Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth.横纹肌肉瘤的功能丧失筛选鉴定出 CRKL-YES 是肿瘤生长的关键信号。
Oncogene. 2013 Nov 21;32(47):5429-38. doi: 10.1038/onc.2012.590. Epub 2013 Jan 14.